CANCER FUND
Cancer Fund, established in 2018 and based in Phoenix, Arizona, is a venture capital firm focused on advancing innovations in cancer treatment and management. The firm seeks to generate both impact and financial returns by supporting startups that are developing new therapies, diagnostics, and preventive technologies. With a commitment to enhancing patient outcomes, increasing access to care, and reducing healthcare costs, Cancer Fund aims to invest up to $30 million from pre-seed to Series D stages. The firm facilitates the progression of cancer innovations through regulatory approvals, technical validation, and early market adoption, positioning itself as a key player in the fight against cancer.
AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.